RP-UPLC-MS Analysis (Lipid Profiling) of Organic Extracts
UPLC-MS Analysis -MS conditions. Mass spectrometry was performed using a Xevo G2 after reconstitution in 50%, 75% and 95% ACN.G,H,I) XIC of the ion attributed to hypoxanthine after reconstitution in 50%, 75% and 95% ACN. J,K,L) XIC of the ion attributed to inosine after reconstitution in 50%, 75% and 95% ACN. PC:
phosphatidylcholine.
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Figure S-3: System pressure trace of two injections before and after HILIC-UPLC-MS analysis of 300 aqueous plaque extracts (Inset: Expansion of the part exhibiting the highest pressure).
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Figure S-4: Effect on hydrophilic compounds of the composition of the reconstitution solvent mixture. A,B,C) 50%, 75% and 95% acetonitrile. Insets: Expansions of the chromatogram portions where elution of the most hydrophilic compounds is detected.
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Figure S-6: Comparison of chromatograms generated by HILIC and RP UPLC-MS using aqueous atherosclerotic plaque extracts. Base peak intensity (BPI) chromatograms of a pooled extract for A) HILIC and B) RP. BPI chromatogram of an extraction blank using C) HILIC and D) RP chromatography. Extracted ion chromatograms demonstrating the chromatographic peak corresponding to HILIC and RP respectively of: E) and F) adenosine; G) and H) carnitine; I) and J) creatine; K) and L) glycerophosphocholine. Efforts were made to ensure that the conditions for the two analyses were as similar as possible: same MS instrument; identical MS parameters; reconstitution in 50% acetonitrile for HILIC and 50% methanol for RP. For RP the elution gradient was set 0-100% mobile phase B (0-22 min), 100% mobile phase B (22-29 min) and followed by a re-equilibration to initial conditions for 3min (mobile phase A: water, 0.1% formic acid; mobile phase B: methanol, 0.1% formic acid). HILIC conditions were similar to the optimized workflow described in the Experimental Section, but not identical.
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Figure S-7: Base peak intensity (BPI) chromatograms of tested biological matrices using the methodologies described. HILIC-UPLC-MS BPI chromatograms of A) positive electrospray ionization mode (ESI+) and B) negative electrospray ionization mode (ESI-) from aqueous extracts obtain from human adipose tissue. Reversed phase BPI chromatograms obtained from the lipid profiling method from: C,D) ESI+ and ESI-of rat plasma organic extracts; E,F) ESI+ and ESI-murine plasma organic extracts; G,H) ESI+ and ESI-of the human plasma organic extracts; I,J) ESI+ and ESI-of bovine liver tissue organic extracts; K,L) ESI+ and ESI-of human adipose tissue organic extracts.
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Figure S-8: Carry over effect tests conducted for the RP lipid profiling method. At the end of the lipid profiling run an organic pooled extract sample was injected followed by an immediate injection of a system blank (system blank refers to the high purity solvent mixture used only for reconstitution of the samples). Base peak intensity chromatograms of A) RP lipid profiling positive polarity mode of an organic pooled extract sample (red) followed by a system blank sample (green). B) RP lipid profiling negative polarity mode of an organic pooled extract sample (red) followed by a system blank sample (green).
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Figure S-9: Extracted ion chromatogram demonstrating the separation of three isobaric phosphatidylglycerols (PG), using the RP lipid profiling method.
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Figure S-10: The process of removing artefactual features induced by sample preparation, using multivariate data analysis. A) Scores plots of an OPLS-DA fitted model for tissue extract (green) and extraction blank (blue) samples. B) S-plots of the OPLS-DA model demonstrating in red the features attributed to the sample preparation procedure. C) PCA scores and D) loadings plots of the same samples and features. E), F) and G) plots demonstrating intensities of features per sample attributed to sample preparation and indicated in the S-plot and loadings plot. H), I) and J) plots demonstrating intensities of features per sample not considered as being induced by the sample preparation procedure (i.e.
true metabolic features) and indicated in the S-plot and loadings plot.
S-14 
S-17
Figure S-14: An overview of the primary metabolic pathways obtained from the KEGG database. A total of 49 metabolites were mapped to these pathways and are indicated with a red dot.
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Figure S-15: List of canonical pathways covered with structurally assigned metabolites, using the Ingenuity Pathway Analysis software.
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Figure S-16: List of biological functions covered with structurally assigned metabolites, using the Ingenuity Pathway Analysis software.
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Figure S-17: List of toxicity functions covered with structurally assigned metabolites, using the Ingenuity Pathway Analysis software. loadings plots using the lipid profiling ESI-analysis.
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